At the same time, market competition may eventually drive down costs, increasing affordability
Regular exercise and a balanced diet, including lean protein, fruits, vegetables, and whole grains, are key to managing type 2 diabetes and promoting weight loss
Risk is further increased in patients with: Pre-existing cardiac conditions Electrolyte imbalances (e.g., low potassium or magnesium) A personal or family history of long QT syndrome Concurrent use of CYP2C19 inhibitors (e.g., omeprazole, esomeprazole, cimetidine), which can raise escitalopram levels Where a combination of QT-prolonging medicines is clinically necessary, a baseline ECG and electrolyte check should be considered
A systematic review and meta-analysis published in Diabetes, Obesity, & Metabolism concluded that injecting semaglutide weekly may help lower blood sugar, body weight, and blood pressure in type II diabetes patients
While some may frown upon those using these injectable weight loss drugs for taking the easy way out or cheating, ongoing studies continue to yield positive findings for not only weight loss and blood sugar control but also disease prevention, making their appeal broader than just a quick-fix jab for shedding excess weight
